Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America

Carregando...
Imagem de Miniatura
Citações na Scopus
7
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
W B SAUNDERS CO-ELSEVIER INC
Autores
VILALTA, Anna Curto
PEREIRA, Gustavo
GONCALVES, Luciana L.
TORRE, Aldo
DIAZ, Juan Manuel
GADANO, Adrian C.
MATTOS, Angelo Z.
MENDES, Liliana S. C.
Citação
GASTROENTEROLOGY, v.165, n.3, p.696-716, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND & AIMS: Genetic ancestry or racial differences in health outcomes exist in diseases associated with systemic inflammation (eg, COVID-19). This study aimed to investigate the association of genetic ancestry and race with acute-on chronic liver failure (ACLF), which is characterized by acute systemic inflammation, multi-organ failure, and high risk of short-term death. METHODS: This prospective cohort study analyzed a comprehensive set of data, including genetic ancestry and race among several others, in 1274 patients with acutely decompensated cirrhosis who were nonelectively admitted to 44 hospitals from 7 Latin American countries. RESULTS: Three hundred ninety-five patients (31.0%) had ACLF of any grade at enrollment. Patients with ACLF had a higher median percentage of Native American genetic ancestry and lower median percentage of European ancestry than patients without ACLF (22.6% vs 12.9% and 53.4% vs 59.6%, respectively). The median percentage of African genetic ancestry was low among patients with ACLF and among those without ACLF. In terms of race, a higher percentage of patients with ACLF than patients without ACLF were Native American and a lower percentage of patients with ACLF than patients without ACLF were European American or African American. In multivariable analyses that adjusted for differences in sociodemographic and clinical characteristics, the odds ratio for ACLF at enrollment was 1.08 (95% CI, 1.03-1.13) with Native American genetic ancestry and 2.57 (95% CI, 1.84-3.58) for Native American race vs European American race CONCLUSIONS: In a large cohort of Latin American patients with acutely decompensated cirrhosis, increasing percentages of Native American ancestry and Native American race were factors independently associated with ACLF at enrollment.
Palavras-chave
Systemic Inflammation, Ethnicity, Sociodemographic Data, Liver Transplantation, Outcomes
Referências
  1. Arroyo V, 2020, NEW ENGL J MED, V382, P2137, DOI 10.1056/NEJMra1914900
  2. Bajaj JS, 2014, HEPATOLOGY, V60, P250, DOI 10.1002/hep.27077
  3. Centers for Disease Control and Prevention, 2020, CAS DAT SURV COVID 1
  4. Fernández J, 2007, GASTROENTEROLOGY, V133, P818, DOI 10.1053/j.gastro.2007.06.065
  5. Gu WY, 2022, LANCET REG HEALTH-EU, V12, DOI 10.1016/j.lanepe.2021.100240
  6. Hernaez R, 2019, J HEPATOL, V70, P639, DOI 10.1016/j.jhep.2018.12.018
  7. Jalan R, 2014, J HEPATOL, V61, P1038, DOI 10.1016/j.jhep.2014.06.012
  8. Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209
  9. Mahmud N, 2019, HEPATOLOGY, V69, P2150, DOI 10.1002/hep.30494
  10. Moreau R, 2013, GASTROENTEROLOGY, V144, P1426, DOI 10.1053/j.gastro.2013.02.042
  11. Nédélec Y, 2016, CELL, V167, P657, DOI 10.1016/j.cell.2016.09.025
  12. Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686
  13. Richardus JH, 2001, AM J PUBLIC HEALTH, V91, P1251, DOI 10.2105/AJPH.91.8.1251
  14. Sarin SK, 2019, HEPATOL INT, V13, P353, DOI 10.1007/s12072-019-09946-3
  15. Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257
  16. Trebicka J, 2020, J HEPATOL, V73, P842, DOI 10.1016/j.jhep.2020.06.013
  17. Trebicka J, 2021, J HEPATOL, V74, P1097, DOI 10.1016/j.jhep.2020.11.019
  18. van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463
  19. Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4